Key statistics
On Friday, Lexaria Bioscience Corp (LEXX:NAQ) closed at 3.26, 283.53% above the 52 week low of 0.85 set on Oct 09, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.20 |
---|---|
High | 3.28 |
Low | 3.05 |
Bid | 2.91 |
Offer | 3.63 |
Previous close | 3.15 |
Average volume | 101.55k |
---|---|
Shares outstanding | 15.81m |
Free float | 14.27m |
P/E (TTM) | -- |
Market cap | 51.54m USD |
EPS (TTM) | -0.4455 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Drug-Delivery System Improves Way Molecules Enter Bloodstream
- Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of GLP-1 Agonists Through Proprietary Drug-Delivery Platform
- Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Studies of Proprietary Platform in Multibillion-Dollar GLP-1 Drug Space
- Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating Proprietary Drug-Delivery Platform for Improved Efficacy of GLP-1 Drugs